Literature DB >> 19592000

Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.

Antti Riikola1, Kalle Sipilä, Mika Kähönen, Antti Jula, Markku S Nieminen, Leena Moilanen, Y Antero Kesäniemi, Terho Lehtimäki, Janne Hulkkonen.   

Abstract

OBJECTIVE: Inflammatory factors modify the risk of cardiovascular diseases and atherosclerosis. The single base genetic polymorphism in the promoter region of inflammatory cytokine interleukin-6 (IL6 -174 G>C, rs1800795) is associated with the variation of IL-6 production. The aim of this study was to investigate whether IL6 -174 G>C is associated with the risk factors and early markers of atherosclerosis.
METHODS: As part of Finnish Health 2000 Study, we performed carotid artery ultrasound examinations, IL6 -174 G>C genotyping and cardiovascular risk factor determination for 1334 subjects aged 46-76 years.
RESULTS: In men, serum total cholesterol was higher in IL6 -174 GG (5.70+/-0.88mmol/L) than in the GC (5.51+/-0.98mmol/L) or CC (5.38+/-0.97mmol/L, mean+/-SD, p=0.0059) groups. The same order was seen in LDL-C (GG 3.64+/-0.83mmol/L, GC 3.41+/-0.88mmol/L, CC 3.30+/-0.91mmol/L, p=0.0017). The opposite association was observed with plasma fasting glucose levels (GG 5.93+/-0.97, GC 6.11+/-1.34, CC 6.34+/-1.59mmol/L, p=0.043) and BMI (GG 26.8+/-3.42, GC 27.5+/-4.32, CC 28.0+/-3.81kg/m(2), p=0.027). IL6 -174 allele C homozygous men indicated a trend towards higher systolic blood pressure. IL6 -174 G>C was not associated with carotid artery compliance, intima media thickness or CRP. The effect size of IL6 -174 G>C on cardiovascular risk factors was not significant in women. These results suggest that IL6 -174 G>C modifies the levels of several metabolic risk factors of atherosclerosis in men.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592000     DOI: 10.1016/j.atherosclerosis.2009.06.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  16 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels.

Authors:  Tina Levstek; Nik Podkrajšek; Andreja Rehberger Likozar; Miran Šebeštjen; Katarina Trebušak Podkrajšek
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-22

3.  Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jihyun Lee; William M Baldwin; Chih-Yuan Lee; Stephen Desiderio
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

4.  CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction.

Authors:  Lidio Gonçalves Lima-Neto; Rosario Dominguez Crespo Hirata; André Ducati Luchessi; Vivian Nogueira Silbiger; Marco Antonio Stephano; Marcelo Ferraz Sampaio; Dikran Armaganijan; Mario Hiroyuki Hirata
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 5.  Inflammation and cardiac outcome.

Authors:  Philipp J Hohensinner; Alexander Niessner; Kurt Huber; Cornelia M Weyand; Johann Wojta
Journal:  Curr Opin Infect Dis       Date:  2011-06       Impact factor: 4.915

6.  The interleukin-6 gene promoter polymorphism -174 and atherosclerotic events in overweight transplanted patients.

Authors:  Jamal Bamoulid; Cécile Courivaud; Marina Deschamps; Béatrice Gaugler; Pierre Tiberghien; Jean-Marc Chalopin; Philippe Saas; Didier Ducloux
Journal:  J Transplant       Date:  2011-06-01

7.  Modifying effect of a common polymorphism in the interleukin-6 promoter on the relationship between long-term exposure to traffic-related particulate matter and heart rate variability.

Authors:  Martin Adam; Medea Imboden; Eva Boes; Emmanuel Schaffner; Nino Künzli; Harish Chandra Phuleria; Florian Kronenberg; Jean-Michel Gaspoz; David Carballo; Nicole Probst-Hensch
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

8.  Associations of the TNF-alpha -308 G/A, IL6 -174 G/C and AdipoQ 45 T/G polymorphisms with inflammatory and metabolic responses to lifestyle intervention in Brazilians at high cardiometabolic risk.

Authors:  Maira Lr Curti; Milena M Pires; Camila R Barros; Antonela Siqueira-Catania; Marcelo Macedo Rogero; Sandra Rg Ferreira
Journal:  Diabetol Metab Syndr       Date:  2012-11-24       Impact factor: 3.320

Review 9.  The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids.

Authors:  Yael T Joffe; Malcolm Collins; Julia H Goedecke
Journal:  Nutrients       Date:  2013-05-21       Impact factor: 5.717

10.  Interleukin-6 gene polymorphisms, dietary fat intake, obesity and serum lipid concentrations in black and white South African women.

Authors:  Yael T Joffe; Lize van der Merwe; Juliet Evans; Malcolm Collins; Estelle V Lambert; Alison V September; Julia H Goedecke
Journal:  Nutrients       Date:  2014-06-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.